Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
D000244:Adenosine Diphosphate / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy*; D001792:Blood Platelets / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D054833:Isoindoles; D010654:Phenylbutyrates / Q000008:administration & dosage / Q000627:therapeutic use*; D010974:Platelet Aggregation / Q000187:drug effects*; D010978:Platelet Factor 4 / Q000032:analysis
D007211:Indoles; D054833:Isoindoles; D010654:Phenylbutyrates; D010978:Platelet Factor 4; D000244:Adenosine Diphosphate; C020371:indobufen; D005340:Fibrinogen